# Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid

> **NCT01094977** · PHASE3 · SUSPENDED · sponsor: **The Hospital for Sick Children** · enrollment: 90 (estimated)

## Conditions studied

- Craniosynostoses

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Tranexamic Acid
- **DRUG:** Saline Placebo

## Key facts

- **NCT ID:** NCT01094977
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2010-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 90 (ESTIMATED)
- **Why stopped:** Inadequate funding
- **Last updated:** 2019-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01094977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01094977, "Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01094977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*